The ROE as of November 2024 (TTM) for Alimera Sciences, Inc. (ALIM) is -33.70%

According to Alimera Sciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -33.70%. This represents a change of 286.52% compared to the average of -8.72% of the last 4 quarters.

Alimera Sciences, Inc. (ALIM) Historical ROE (quarterly & annually)

How has ALIM ROE performed in the past?

The mean historical ROE of Alimera Sciences, Inc. over the last ten years is -55.50%. The current -33.70% ROE has changed -39.28% with respect to the historical average. Over the past ten years (40 quarters), ALIM's ROE was at its highest in in the December 2021 quarter at 157.62%. The ROE was at its lowest in in the March 2019 quarter at -427.71%.

Alimera Sciences, Inc. (ALIM) ROE by Quarter and Year

Discovering the peaks and valleys of Alimera Sciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Alimera Sciences, Inc. (ALIM) Average ROE

How has ALIM ROE performed in the past?

The current ROE of Alimera Sciences, Inc. (ALIM) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Alimera Sciences, Inc. (ALIM) ROE vs. Peers

How is ALIM’s ROE compared to its peers?

Alimera Sciences, Inc.’s ROE is greater than Shuttle Pharmaceuticals Holdings, Inc. (-582.98%), less than Lifecore Biomedical, Inc. (17.23%), greater than Mallinckrodt plc (-74.45%), greater than Journey Medical Corporation (-132.10%), greater than Lucy Scientific Discovery Inc. (-296.96%), less than Adamis Pharmaceuticals Corporation (0.33%), greater than Organogenesis Holdings Inc. (-2.69%), less than Cyclo Therapeutics, Inc. (749.85%), less than Athenex, Inc. (21.51%), greater than MedMen Enterprises Inc. (-96.37%), greater than China Pharma Holdings, Inc. (-63.93%), greater than Halo Collective Inc. (-165.53%), greater than China SXT Pharmaceuticals, Inc. (-83.62%), greater than Petros Pharmaceuticals, Inc. (-76.66%),

Build a custom stock screener for Alimera Sciences, Inc. (ALIM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alimera Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alimera Sciences, Inc. (ALIM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alimera Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.